Delivery Order SPE2DB22D2206-SPE2DB23FJS23
Award Date 8/10/23
Potential Completion Date 8/11/23
Potential Value $11
Federal Agency
Awardee
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- Amerisourcebergen Drug Corporation, a subsidiary of Amerisourcebergen Corporation, has been awarded a $37,760 delivery order by the Defense Logistics Agency to provide 50 mg/2 ml vials of methotrexate. The firm fixed price order is for performance from September 11-12, 2023 at Amerisourcebergen's facility in Conshohocken, Pennsylvania. No additional details were provided regarding the original solicitation or whether this delivery order is associated with a larger governmentwide acquisition...
- Amerisourcebergen Drug Corporation, a subsidiary of Amerisourcebergen Corporation, has been awarded a $18,880 delivery order by the Defense Logistics Agency to provide 50 mg/2 ml vials of methotrexate. The firm fixed price order is for performance from August 15-16, 2023 at Amerisourcebergen's facility in Conshohocken, Pennsylvania. No additional details were provided regarding the original solicitation or whether this delivery order is associated with a larger governmentwide acquisition...
- Amerisourcebergen Drug Corporation, a subsidiary of Amerisourcebergen Corporation, has been awarded a $40,900 firm fixed price delivery order by the Defense Logistics Agency to provide 4562172665 units of methotrexate 50 mg/2 ml vials. The single day contract has a period of performance from September 14 to 15, 2023, with all work to be conducted by Amerisourcebergen at its facility in Conshohocken, Pennsylvania. As the Defense Logistics Agency is responsible for worldwide logistics support of...
- Amerisourcebergen Drug Corporation, a division of Amerisourcebergen Corporation, has been awarded a delivery order against the Defense Logistics Agency's prime vendor program. The firm fixed price order, valued at $18,880, is to provide 50 mg/2 ml vials of methotrexate to a Defense Logistics Agency customer. Performance will occur at Amerisourcebergen's facility in Conshohocken, Pennsylvania over a one day period from July 10-11, 2023. No subcontractors or set aside designations were identified....
- Amerisourcebergen Drug Corporation, a subsidiary of Amerisourcebergen Corporation, has been awarded a $18,880 delivery order by the Defense Logistics Agency to provide 50 mg/2 ml vials of methotrexate. The firm fixed price order is for performance over a one day period from August 24-25, 2023 at Amerisourcebergen's facility in Conshohocken, Pennsylvania. No major subcontractors or set aside designations were identified. The Defense Logistics Agency utilizes contracts such as this to...
- The Defense Logistics Agency awarded a $18,880 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 50 mg/2 mL vials of methotrexate. As the prime contractor, Amerisourcebergen will deliver the pharmaceutical to a Defense Logistics Agency facility located in Conshohocken, Pennsylvania between August 15-16, 2023. Amerisourcebergen Corporation is the parent company of Amerisourcebergen Drug Corporation. No subcontractors or set aside designations were identified. The...
- Amerisourcebergen Drug Corporation, a subsidiary of Amerisourcebergen Corporation, has been awarded a $18,880 delivery order by the Defense Logistics Agency to provide 50 mg/2 ml vials of methotrexate. The firm fixed price order is for a one-day period of performance in Conshohocken, Pennsylvania under an existing DLA pharmaceuticals contract vehicle. As the prime contractor, Amerisourcebergen will deliver the chemotherapy drug to support the DLA's medical supply needs for the Department of...
- Amerisourcebergen Drug Corporation, a division of Amerisourcebergen Corporation, has been awarded a $31,620 firm fixed price delivery order by the Defense Logistics Agency to provide 50 mg/2 ml vials of methotrexate. The single day contract issued on August 10, 2023 has a period of performance through August 11, 2023. The place of performance is Amerisourcebergen's facility in Conshohocken, Pennsylvania. No additional details were provided regarding the original solicitation or whether this...
- Amerisourcebergen Drug Corporation, a subsidiary of Amerisourcebergen Corporation, has been awarded a $18,880 delivery order by the Defense Logistics Agency to supply 50 mg/2 ml vials of methotrexate. The firm fixed price order is for performance from August 2-3, 2023, with delivery to occur at Amerisourcebergen's facility in Conshohocken, Pennsylvania. No major subcontractors or set aside designations were identified. The Defense Logistics Agency routinely issues such orders under its Prime...
- Amerisourcebergen Drug Corporation, a division of Amerisourcebergen Corporation, has been awarded a $18,880 firm fixed price delivery order by the Defense Logistics Agency to provide 50 mg/2 ml vials of methotrexate. The single day contract has a period of performance from August 24-25, 2023 and will be performed in Conshohocken, Pennsylvania. No set aside designation or subcontracting details were provided. The Defense Logistics Agency routinely issues delivery orders against its Prime Vendor...
- SPE2DB22D2206Indefinite Delivery Contract
- SPE2DB22D2206-SPE2DB23FJS23Delivery Order
Amerisourcebergen Drug Corporation, a subsidiary of Amerisourcebergen Corporation, has been awarded a delivery order valued at ten thousand five hundred forty dollars by the Defense Logistics Agency to provide fifty milligrams per two milliliters vials of methotrexate. The firm fixed price contract requires delivery of the pharmaceutical to a facility in Conshohocken, Pennsylvania within a one day period beginning August tenth and concluding on August eleventh of twenty twenty-three. The Defense Logistics Agency will utilize the methotrexate to support its medical logistics programs. No set aside designation or subcontractors are associated with this delivery order issued against an existing DLA pharmaceuticals contract vehicle.
Generated 12/18/23, 9:12 PM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $11 | 8/10/23 |